HECL to distribute Cardax astaxanthin dietary supplement ZanthoSyn in China
Cardax, a Hawaii-based pharma company has inked a purchase agreement with Hong Kong-based Health Elite Club (HECL) for distribution of ZanthoSyn, its astaxanthin dietary supplement for inflammatory health and longevity, in China, Macau, Taiwan and Hong Kong.
HECL targets affluent and high-profile Chinese in its membership-based, invitation-only club and will sell most of the ZanthoSyn products online.
The astaxanthin dietary supplement will be distributed in the agreed regions under Puerfons, the house brand of HECL while having all packaging and marketing materials to highlight the ZanthoSyn brand.
David G. Watumull – President and CEO of Cardax, said: “We are very pleased to be working with such a highly entrepreneurial company as HECL.
“HECL’s distribution model looks quite promising and their principals are highly credible. We look forward to building our relationship as HECL’s business grows in China.”
Under the purchase agreement, HECL will handle all regulatory approvals in the agreed areas.
Li Wu – Chairman of HECL said: “U.S. products with scientific and manufacturing credibility such as ZanthoSyn are highly prized in China and we are excited to bring Puerfons ZanthoSyn into this important market.
“With China’s increasing industrialization and associated pollution challenges, inflammatory health, with its relationship to longevity, is increasingly important, especially to its rapidly growing aging population.”
Cardax is also working on another product CDX-085, which is a ZanthoSyn product for more concentrated astaxanthin product applications.
The company also announced that ZanthoSyn can be bought from GNC stores in Guam.